AG

Aman Gahalot

Active Director Designated Partner DIN 11693649
DIN 11693649 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Aman Gahalot

Data last updated:

Aman Gahalot is a Designated Partner at Ayuventus International Pharmaceuticals Llp (since 2026).

DIN 11693649
Primary Designation Designated Partner
First Appointment 29 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Apr 20262026Active

Board colleagues of Aman Gahalot

NameDINCompanyDesignation
Siddhant Babu11693648Ayuventus International Pharmaceuticals LlpDesignated Partner
Suraj Bhardwaj11693650Ayuventus International Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Ayuventus International Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Aman Gahalot

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aman Gahalot

Aman Gahalot currently holds 1 directorship: Ayuventus International Pharmaceuticals Llp (Designated Partner, since 29 Apr 2026).

Aman Gahalot was first appointed on 29 Apr 2026 as Designated Partner at Ayuventus International Pharmaceuticals Llp.

The current boards of Aman Gahalot's companies include Siddhant Babu (Ayuventus International Pharmaceuticals Llp), Suraj Bhardwaj (Ayuventus International Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available